Skip to main content

SHINE Technologies' FDA filing for radioisotope clears way for commercial use

Janesville's SHINE Technologies said Friday that the company had submitted a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) for a radioisotope used in cancer treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.